Skip to content

Author

Adnan Amin

We have 15 of 52 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Delivering Degradation: Nanomedicine and Programmable Proximity Platforms for Targeted Protein Degradation

This critical review is an outline of all lipid, polymeric, inorganic, biomimetic, targeted, activatable, and self-assembling delivery systems for TPD, and assess compositional considerations, in vitro and in vivo evidence, challenges for translation, and clinical endpoints required to support delivery-enabled degradat...

Adnan Amin, Touseef Nawaz, Oberdan Oliveira Ferreira et al. · 0 citations
#gene editing Review Sep 2026

CRISPR–cas systems in pharmacology: functional pharmacogenomics, drug screening, resistance, and therapeutic translation

Overall, CRISPR-Cas9 represents a vital platform for future pharmacological innovation, but its broad clinical use may require further validation of safety, efficacy, durability, and accessibility.

Muhammad Saeed Akhtar, Adnan Amin · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.